Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence Read more
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer Read more
Janssen Announces European Commission Approval of Imbruvica (ibrutinib) for Expanded Use in Two Indications Read more